Back to mobile site

H.C. Wainwright Reiterates Buy Rating on Voyager Therapeutics (VYGR)

January 27, 2025 7:22 AM EST Send to a Friend
H.C. Wainwright analyst Patrick R. Trucchio reiterated a Buy rating and $30.00 price target on Voyager Therapeutics (NASDAQ: VYGR).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login